Literature DB >> 17287235

Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis.

Z Khaleeli1, J Sastre-Garriga, O Ciccarelli, D H Miller, A J Thompson.   

Abstract

BACKGROUND: Progression rates in primary progressive multiple sclerosis (PPMS) vary widely and brain magnetisation transfer imaging (MTI) has potential as an early prognostic indicator. We investigated the predictive value of MTI and the longitudinal changes developing over 1 year in early PPMS. AIMS: To determine (1) whether baseline brain MTI parameters in early PPMS predict clinical changes over 1 year, independent of brain volume and (2) whether a change in magnetisation transfer (MT) parameters occurs over 1 year, independent of atrophy.
METHODS: 30 patients with PPMS within 5 years of symptom onset and 15 controls underwent MT and volumetric imaging studies, at baseline and at 1 year. Patients underwent clinical assessment using the Expanded Disability Status Scale (EDSS) and Multiple Sclerosis Functional Composite (MSFC), including the timed walk subtest (TWT). Normalised MT histograms were generated for whole brain, normal appearing brain tissue (NABT) and normal appearing white and grey matter (NAWM and NAGM) segments. Multiple regression analyses were performed to investigate whether baseline MTR parameters predicted clinical change over 1 year, adjusting for baseline brain volume. MTR changes over 1 year were assessed using paired t tests.
RESULTS: In patients, lower baseline NAWM MTR predicted greater deterioration in EDSS and MSFC, particularly in walking ability measured by the TWT, independent of NAWM baseline volume (p = 0.001). NAGM MTR mean (p<0.001), and to a lesser extent NAWM mean (p = 0.011) and lesion MTR (p = 0.03), decreased over 1 year.
CONCLUSIONS: NAWM MTR may provide information on short term clinical prognosis in early PPMS. MTI is sensitive to brain tissue changes over 1 year in early PPMS, which were primarily seen in the NAGM.

Entities:  

Mesh:

Year:  2007        PMID: 17287235      PMCID: PMC2117577          DOI: 10.1136/jnnp.2006.107565

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  38 in total

1.  Cortical lesions in multiple sclerosis.

Authors:  D Kidd; F Barkhof; R McConnell; P R Algra; I V Allen; T Revesz
Journal:  Brain       Date:  1999-01       Impact factor: 13.501

2.  The multiple sclerosis functional composite: different practice effects in the three test components.

Authors:  Alessandra Solari; Davide Radice; Letizia Manneschi; Luisa Motti; Enrico Montanari
Journal:  J Neurol Sci       Date:  2004-11-06       Impact factor: 3.181

3.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.

Authors:  Jeroen J G Geurts; Lars Bö; Petra J W Pouwels; Jonas A Castelijns; Chris H Polman; Frederik Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

Review 4.  How to read a paper. Papers that report diagnostic or screening tests.

Authors:  T Greenhalgh
Journal:  BMJ       Date:  1997-08-30

Review 5.  What's wrong with Bonferroni adjustments.

Authors:  T V Perneger
Journal:  BMJ       Date:  1998-04-18

6.  Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

Authors:  G R Cutter; M L Baier; R A Rudick; D L Cookfair; J S Fischer; J Petkau; K Syndulko; B G Weinshenker; J P Antel; C Confavreux; G W Ellison; F Lublin; A E Miller; S M Rao; S Reingold; A Thompson; E Willoughby
Journal:  Brain       Date:  1999-05       Impact factor: 13.501

7.  Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI.

Authors:  Marco Rovaris; Antonio Gallo; Paola Valsasina; Beatrice Benedetti; Domenico Caputo; Angelo Ghezzi; Enrico Montanari; Maria Pia Sormani; Antonio Bertolotto; Gianluigi Mancardi; Roberto Bergamaschi; Vittorio Martinelli; Giancarlo Comi; Massimo Filippi
Journal:  Neuroimage       Date:  2004-11-26       Impact factor: 6.556

Review 8.  The spectrum of multiple sclerosis: new lessons from pathology.

Authors:  Wolfgang Brück; Christine Stadelmann
Journal:  Curr Opin Neurol       Date:  2005-06       Impact factor: 5.710

9.  Brain MRI correlates of magnetization transfer imaging metrics in patients with multiple sclerosis.

Authors:  M Rovaris; M Bozzali; M Rodegher; C Tortorella; G Comi; M Filippi
Journal:  J Neurol Sci       Date:  1999-06-15       Impact factor: 3.181

10.  Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.

Authors:  Jaume Sastre-Garriga; Gordon T Ingle; Declan T Chard; Mara Cercignani; Lluís Ramió-Torrentà; David H Miller; Alan J Thompson
Journal:  Brain       Date:  2005-04-07       Impact factor: 13.501

View more
  23 in total

1.  Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM.

Authors:  Benedetta Bodini; Zhaleh Khaleeli; Mara Cercignani; David H Miller; Alan J Thompson; Olga Ciccarelli
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

Review 2.  MRI in multiple sclerosis: what's inside the toolbox?

Authors:  Mohit Neema; James Stankiewicz; Ashish Arora; Zachary D Guss; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

Review 3.  The role of advanced magnetic resonance imaging techniques in primary progressive MS.

Authors:  Maria A Rocca; Martina Absinta; Massimo Filippi
Journal:  J Neurol       Date:  2011-08-04       Impact factor: 4.849

4.  Advanced magnetic resonance imaging techniques to better understand multiple sclerosis.

Authors:  Wafaa Zaaraoui; Bertrand Audoin; Jean Pelletier; Patrick J Cozzone; Jean-Philippe Ranjeva
Journal:  Biophys Rev       Date:  2010-04-02

5.  Vitamin D and MRI measures in progressive multiple sclerosis.

Authors:  Justin R Abbatemarco; Robert J Fox; Hong Li; Daniel Ontaneda
Journal:  Mult Scler Relat Disord       Date:  2019-08-13       Impact factor: 4.339

6.  Magnetization transfer imaging in premanifest and manifest Huntington disease.

Authors:  S J A van den Bogaard; E M Dumas; J Milles; R Reilmann; J C Stout; D Craufurd; M A van Buchem; J van der Grond; R A C Roos
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

7.  The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis.

Authors:  Adam B Cohen; Mohit Neema; Ashish Arora; Elisa Dell'oglio; Ralph H B Benedict; Shahamat Tauhid; Daniel Goldberg-Zimring; Christian Chavarro-Nieto; Antonella Ceccarelli; Joshua P Klein; James M Stankiewicz; Maria K Houtchens; Guy J Buckle; David C Alsop; Charles R G Guttmann; Rohit Bakshi
Journal:  J Neuroimaging       Date:  2011-03-29       Impact factor: 2.486

8.  Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.

Authors:  Khaled Abdel-Aziz; Torben Schneider; Bhavana S Solanky; Marios C Yiannakas; Dan R Altmann; Claudia A M Wheeler-Kingshott; Amy L Peters; Brian L Day; Alan J Thompson; Olga Ciccarelli
Journal:  Brain       Date:  2015-04-10       Impact factor: 13.501

9.  A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS.

Authors:  Benedetta Bodini; Mara Cercignani; Ahmed Toosy; Nicola De Stefano; David H Miller; Alan J Thompson; Olga Ciccarelli
Journal:  Hum Brain Mapp       Date:  2013-04-24       Impact factor: 5.038

10.  Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss.

Authors:  Gary Price; Mara Cercignani; Elvina M Chu; Thomas R E Barnes; Gareth J Barker; Eileen M Joyce; Maria A Ron
Journal:  Neuroimage       Date:  2009-07-23       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.